fda semaglutide warning november 2025 The sent a letter to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know Diabetes advocacy group discourages use

Saxenda (liraglutide 3.0 mg) is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with comorbidities

Others may have you start at the next highest dose of 5 mg weekly

Pre-existing vulnerability : People with type 2 diabetes have higher rates of anxiety and depression compared to the general population, which may make them more susceptible to panic symptoms regardless of medication

Some things to consider are: Medical history : Your healthcare provider will look at your overall health and any existing conditions like diabetes, heart disease, or allergies

Our team at Noor Medical Spa is committed to supporting our clients in their weight loss journey